ClinicalTrials.gg
Drug

Deamino Arginine Vasopressin clinical trials

Also written Desmopressin, DDAVP, FE992026 and Minirin.

studies test it
75
open now
11
in phase 3
25
first study started
2003

How each study uses Deamino Arginine Vasopressin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Deamino Arginine Vasopressin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Feb 1978 · DDAVP (NEEDS NO REFRIGERATION) · NDA 017922 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nocturin®
5
Desmopressin Acetate 0.2 mg Tablets
3
Minirin® Melt
3
Desmopressin (DDAVP)
3
Desmopressin Melt
2

Brand

DDAVP
12
Minirin
10
NOCDURNA
1

Development codes

FE992026
11
SER120
3

Other names

Desmopressin
37
Desmopressin Acetate
6

Studies by the year they started

75 studies that test it; most in 2009 (8)

Studies that test Deamino Arginine Vasopressin, by start year
YearStudies
20033
20043
20062
20072
20081
20098
20105
20116
20125
20136
20141
20154
20162
20175
20182
20192
20203
20223
20231
20247
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
12
Phase 3
25
Phase 4
24
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 51

Ferring Pharmaceuticals (15) · Serenity Pharmaceuticals, Inc. (6) · Menoufia University (2) · University of Aarhus (2) · University Hospital, Ghent (2) · Laboratorio Elea Phoenix S.A. (2) · The University of Hong Kong (2) · Rabin Medical Center (2)

Often tested with

Tested in the same studies.

Vitamin D (1) · Ginkgo biloba extract (1) · Aspirin (1) · Human platelet, allogenic (1) · Blood Platelet|Platelet (1) · Tranexamic Acid (1) · Mirabegron (1) · Fesoterodine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test Deamino Arginine Vasopressin, phase 3 first.

Studies

Open first, then newest update. How each study uses Deamino Arginine Vasopressin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test Deamino Arginine Vasopressin →

Given beside what is tested · 5 — Deamino Arginine Vasopressin is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Deamino Arginine Vasopressin

Codes

What other systems call Deamino Arginine Vasopressin · ClinicalTrials.gg INT007318

  • MeSH (NLM) D003894Deamino Arginine VasopressinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) ENR1LLB0FPDESMOPRESSINConfirmed FDA, NLM
  • RxNorm 3251One source FDA

Also registered as desmopressin acetate trihydrate (UNII XB13HYU18U · RxNorm 42634).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.